DHR
Price
$200.68
Change
+$1.05 (+0.53%)
Updated
Jul 8 closing price
Capitalization
184.93B
13 days until earnings call
WST
Price
$220.48
Change
-$1.00 (-0.45%)
Updated
Jul 8 closing price
Capitalization
28.97B
15 days until earnings call
Interact to see
Advertisement

DHR vs WST

Header iconDHR vs WST Comparison
Open Charts DHR vs WSTBanner chart's image
Danaher
Price$200.68
Change+$1.05 (+0.53%)
Volume$4.23M
Capitalization184.93B
West Pharmaceutical Services
Price$220.48
Change-$1.00 (-0.45%)
Volume$645.41K
Capitalization28.97B
DHR vs WST Comparison Chart in %
Loading...
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DHR vs. WST commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a StrongBuy and WST is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (DHR: $200.68 vs. WST: $220.48)
Brand notoriety: DHR and WST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DHR: 112% vs. WST: 104%
Market capitalization -- DHR: $184.93B vs. WST: $28.97B
DHR [@Medical Specialties] is valued at $184.93B. WST’s [@Medical Specialties] market capitalization is $28.97B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DHR’s FA Score shows that 0 FA rating(s) are green whileWST’s FA Score has 0 green FA rating(s).

  • DHR’s FA Score: 0 green, 5 red.
  • WST’s FA Score: 0 green, 5 red.
According to our system of comparison, DHR is a better buy in the long-term than WST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DHR’s TA Score shows that 6 TA indicator(s) are bullish while WST’s TA Score has 6 bullish TA indicator(s).

  • DHR’s TA Score: 6 bullish, 4 bearish.
  • WST’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, WST is a better buy in the short-term than DHR.

Price Growth

DHR (@Medical Specialties) experienced а -0.21% price change this week, while WST (@Medical Specialties) price change was -0.87% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.52%. For the same industry, the average monthly price growth was +0.66%, and the average quarterly price growth was -0.00%.

Reported Earning Dates

DHR is expected to report earnings on Oct 28, 2025.

WST is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical Specialties (+1.52% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($185B) has a higher market cap than WST($29B). WST has higher P/E ratio than DHR: WST (50.25) vs DHR (43.86). DHR YTD gains are higher at: -12.304 vs. WST (-32.581). DHR has higher annual earnings (EBITDA): 7.5B vs. WST (844M). DHR has more cash in the bank: 5.86B vs. WST (854M). WST has less debt than DHR: WST (309M) vs DHR (19.5B). DHR has higher revenues than WST: DHR (23.9B) vs WST (2.95B).
DHRWSTDHR / WST
Capitalization185B29B638%
EBITDA7.5B844M888%
Gain YTD-12.304-32.58138%
P/E Ratio43.8650.2587%
Revenue23.9B2.95B810%
Total Cash5.86B854M687%
Total Debt19.5B309M6,311%
FUNDAMENTALS RATINGS
DHR vs WST: Fundamental Ratings
DHR
WST
OUTLOOK RATING
1..100
1755
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
6594
SMR RATING
1..100
7850
PRICE GROWTH RATING
1..100
5962
P/E GROWTH RATING
1..100
7177
SEASONALITY SCORE
1..100
9595

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DHR's Valuation (49) in the Medical Specialties industry is in the same range as WST (77). This means that DHR’s stock grew similarly to WST’s over the last 12 months.

DHR's Profit vs Risk Rating (65) in the Medical Specialties industry is in the same range as WST (94). This means that DHR’s stock grew similarly to WST’s over the last 12 months.

WST's SMR Rating (50) in the Medical Specialties industry is in the same range as DHR (78). This means that WST’s stock grew similarly to DHR’s over the last 12 months.

DHR's Price Growth Rating (59) in the Medical Specialties industry is in the same range as WST (62). This means that DHR’s stock grew similarly to WST’s over the last 12 months.

DHR's P/E Growth Rating (71) in the Medical Specialties industry is in the same range as WST (77). This means that DHR’s stock grew similarly to WST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DHRWST
RSI
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
45%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
64%
Momentum
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
63%
MACD
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
59%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 6 days ago
56%
Bullish Trend 15 days ago
68%
Declines
ODDS (%)
Bearish Trend 9 days ago
59%
Bearish Trend 1 day ago
58%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
53%
Aroon
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IWS134.320.48
+0.36%
iShares Russell Mid-Cap Value ETF
DOGG20.110.04
+0.18%
FT Vest DJIA® Dogs 10 Trgt Inc ETF
PSTR27.760.05
+0.17%
PeakShares Sector Rotation ETF
INCM27.220.04
+0.15%
Franklin Income Focus ETF
SRET21.11-0.12
-0.57%
Global X SuperDividend® REIT ETF